The panel discussion will unpack Orexo’s decisive US patent litigation victory over Sun Pharma, a milestone case that underscores the critical value of a robust intellectual property strategy.
This case offers important insights for innovators, pharma companies, biotech firms, and IP professionals facing aggressive generic competition.
Why attend
Learn from the experts - Hear from those who lived it:
- Orexo – on the effective use of IP to meet its business objectives, safeguarding life‑changing treatments for opioid dependence;
- Steptoe - US litigators who brought and successfully argued the case before the court; and
- Potter Clarkson – Orexo’s patent attorneys who had a key, central role in preparing the ground for that success
Understand the strategy - See how targeted IP planning can protect market share and innovation pipelines
Take away real‑world lessons - Practical insights on resilience, litigation strategy, and long‑term protection of breakthrough work
Event format
- Panel discussion with candid, behind‑the‑scenes perspectives
- Interactive Q&A session - get your questions answered by the case’s key players
- Networking and refreshments to connect with peers in pharma, biotech, and IP law
Who should attend
- Pharma and biotech executives
- IP lawyers, patent attorneys, and in‑house counsel
- R&D and innovation leaders
- Investors and stakeholders in healthcare innovation
Reserve your place today - spaces are limited, and this is a unique opportunity to hear the inside story of a case that’s shaping IP strategy in life sciences.
